Tender Overview
- Organization: Indian Army, Department Of Military Affairs; procurement location in CENTRAL DELHI, DELHI - 110002. Channeling a tender for the Tab Acalabrutinib 100 mg and Nerivio Device categories. BOQ shows 0 items and no start/end dates, indicating either a placeholder or early release stage. The absence of specifications suggests bidders must await further detail or rely on standard government procurement processes. Unique context includes a high-security government procurement background with potential medical device and pharmaceutical components. The lack of concrete values or delivery terms requires bidders to monitor updates and prepare standard compliance documentation. Key differentiator is the explicit listing of product names in the category without accompanying technical scope.
Technical Specifications & Requirements
- Specifications: No technical specifications provided in the tender data. Referenced products: Tab Acalabrutinib 100 mg and Nerivio Device. There are no listed quantities, delivery locations beyond the general Central Delhi address, or installation requirements. No Estimated Value or EMD is disclosed. Absence of BOQ items indicates no priced scope yet. Bidders should prepare to demonstrate capability for pharmaceutical/medical device procurement and ensure compliance with standard government medical supply practices. Awaiting ATC document for any further technical criteria.
Terms, Conditions & Eligibility
- EMD/Security: Not disclosed in the available data.
- Delivery Timeline: Not specified.
- Payment Terms: Not specified.
- Documents Required: Not detailed here; expect standard GST, PAN, experience, financials once ATC/Terms are finalized. Indicative approach: monitor official ATC and Terms for exact bidder submission requirements. Ensure readiness to comply with security clearance and medical procurement norms applicable to the Indian Army.
- Special Clauses: None explicit in the current data; anticipate standard civil/military procurement clauses once ATC is issued.